ALBIREO PHARMA INC's ticker is ALBO and the CUSIP is 01345P106. A total of 105 filers reported holding ALBIREO PHARMA INC in Q2 2022. The put-call ratio across all filers is 0.28 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $266,711 | +120.4% | 12,342 | +98.0% | 0.00% | – |
| Q3 2022 | $121,000 | -91.9% | 6,234 | -91.7% | 0.00% | – |
| Q2 2022 | $1,495,000 | +2.6% | 75,265 | +54.1% | 0.00% | – |
| Q1 2022 | $1,457,000 | -5.6% | 48,844 | -26.3% | 0.00% | – |
| Q4 2021 | $1,544,000 | +258.2% | 66,286 | +379.7% | 0.00% | – |
| Q3 2021 | $431,000 | +12.8% | 13,817 | +27.1% | 0.00% | – |
| Q2 2021 | $382,000 | -54.8% | 10,869 | -54.7% | 0.00% | – |
| Q1 2021 | $846,000 | +170.3% | 24,011 | +188.3% | 0.00% | – |
| Q4 2020 | $313,000 | -0.3% | 8,329 | -11.4% | 0.00% | – |
| Q3 2020 | $314,000 | +32.5% | 9,401 | +5.3% | 0.00% | – |
| Q2 2020 | $237,000 | +3.9% | 8,928 | -36.0% | 0.00% | – |
| Q1 2020 | $228,000 | +132.7% | 13,948 | +263.2% | 0.00% | – |
| Q4 2019 | $98,000 | +8.9% | 3,840 | -14.7% | 0.00% | – |
| Q3 2019 | $90,000 | -34.8% | 4,504 | +5.8% | 0.00% | – |
| Q2 2019 | $138,000 | +51.6% | 4,257 | +49.2% | 0.00% | – |
| Q1 2019 | $91,000 | -42.8% | 2,853 | -55.9% | 0.00% | – |
| Q4 2018 | $159,000 | +39.5% | 6,469 | +87.6% | 0.00% | – |
| Q3 2018 | $114,000 | +111.1% | 3,449 | +122.8% | 0.00% | – |
| Q2 2018 | $54,000 | +12.5% | 1,548 | +4.4% | 0.00% | – |
| Q1 2018 | $48,000 | – | 1,483 | +36975.0% | 0.00% | – |
| Q4 2017 | $0 | -100.0% | 4 | -91.7% | 0.00% | – |
| Q3 2017 | $1,000 | -66.7% | 48 | -65.0% | 0.00% | – |
| Q2 2017 | $3,000 | 0.0% | 137 | -31.5% | 0.00% | – |
| Q4 2016 | $3,000 | – | 200 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Prosight Management, LP | 514,082 | $11,973,000 | 7.17% |
| Privium Fund Management B.V. | 379,117 | $8,959,000 | 1.78% |
| Birchview Capital, LP | 113,000 | $2,632,000 | 1.70% |
| Sio Capital Management, LLC | 213,913 | $4,982,000 | 1.50% |
| Perceptive Advisors | 4,720,278 | $109,936,000 | 0.85% |
| Chicago Capital, LLC | 849,239 | $19,779,000 | 0.74% |
| APOGEM CAPITAL LLC | 38,601 | $899,000 | 0.59% |
| Samsara BioCapital, LLC | 100,000 | $2,329,000 | 0.45% |
| Artal Group S.A. | 600,000 | $13,974,000 | 0.38% |
| RICE HALL JAMES & ASSOCIATES, LLC | 458,011 | $10,667,000 | 0.38% |